Trial Profile
Efficacy and safety study of prednisone and sirolimus in patients with Erdheim-Chester disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Prednisone (Primary) ; Sirolimus (Primary)
- Indications Erdheim-Chester disease
- Focus Adverse reactions; Therapeutic Use
- 03 Dec 2015 New trial record